About Precision Medicine MCP
Precision Medicine MCP is an MCP server published by lynnlangit in the Developer Tools category: precision Medicine MCP Platform: A set of bioinformatics servers + tools - production multiomics/genomics + spatial transcriptomics. Example and demo for ovarian cancer. It has been installed 0 times through Conduid.
The repository has 12 stars and 8 forks, with the last commit 6 months ago. Six months or more without a commit doesn't mean the server is broken, but check the open issues (0) before depending on it in production.
Install
npx precision-medicine-mcpThis server has no ConduID identity, so agent calls to it are not receipted. Pin the version you install and review the source before granting it credentials.
Ask AI
Ask AI about Precision Medicine MCP
Powered by Claude · Grounded in docs
Security checks
- ·README presentNot checked yet.
- ·License declaredNot checked yet.
- ·Tests presentNot checked yet.
- ·Dependencies pinnedNot checked yet.
- ·No dynamic code executionNot checked yet.
- !Scoped permissionsDoesn't declare a permission scope. Assume it can do anything its process can.
Releases
README
Precision Medicine MCP Platform
Dedicated to PatientOne -- a dear friend who passed from High-Grade Serous Ovarian Carcinoma in 2025.
The Problem
Standard HGSOC workup (BRCA1/2, HRD panel, CT imaging) generates no immunotherapy hypotheses. Manual multi-modal analysis across genomics, spatial transcriptomics, imaging, and clinical data takes an estimated 40 hours and $6,000-9,000 per patient -- making integrated analysis clinically impractical.
The Platform
A 19-server MCP architecture orchestrated by AI (Claude + Gemini) executes a 5-stage pipeline:
flowchart LR
A["1 Data<br/>Acquisition"] --> B["2 Spatial<br/>Deconvolution"]
B --> C["3 Target<br/>Profiling"]
C --> D["4 Causal<br/>Inference"]
D --> E["5 Report"]
subgraph servers [" "]
direction TB
S1["EHR · GEO · TCGA"]
S2["Spatial · DeepCell · CIBERSORTx"]
S3["OpenTargets · Neoantigen"]
S4["Perturbation · Quantum"]
S5["Patient Report"]
end
A --- S1
B --- S2
C --- S3
D --- S4
E --- S5
AI(["AI Orchestrator<br/>Claude + Gemini"]) -.-> A
AI -.-> B
AI -.-> C
AI -.-> D
AI -.-> E
Architecture at a glance
+--------------------------------------+
| CLIENT LAYER |
| Claude Desktop / Hospital EHR |
| Adapter / Research Notebook |
+----------------+-----------------+
|
MCP (FastMCP >= 2.13)
|
+---------------------------------------------------------------+
| |
| DATA ACQUISITION ANALYSIS & INFERENCE REPORTING |
| |
| mockepic spatialtools (16) patient- |
| epic multiomics (10) report (5) |
| geodownload perturbation (8) |
| mocktcga quantum-fidelity(6) |
| genomic-results opentargets (6) |
| fgbio neoantigen (6) |
| cibersortx (5) |
| [7 servers] openimagedata (5) [1 server] |
| deepcell (3) |
| cell-classify (3) |
| cardiometabolic (5) |
| |
| [11 servers] |
+---------------------------------------------------------------+
19 custom servers, 104 tools
| Servers | Tools | |
|---|---|---|
| Custom | 19 servers | 104 tools |
| External | 6 connectors (PubMed, bioRxiv, ClinicalTrials.gov, Seqera, cBioPortal, HuggingFace) | 46 tools |
All tools accessible via natural language. Every AI result requires clinician APPROVE/REVISE/REJECT. HIPAA-compliant. See Server Registry.
The Results
The platform surfaces clinically actionable findings that standard workup cannot reach — validated across three independent use cases:
| Use Case | Patient | Key Finding Missed by Standard Workup |
|---|---|---|
| HGSOC (Stage IV) | PAT001 | 3 investigational paths: neoantigen vaccine (RMPEAAPPV IC50 7.8 nM), NNMT/CAF inhibition, convergent checkpoint blockade |
| ER+ Breast Cancer | PAT002 | HRD 35 below myChoice threshold but PARP-eligible via BRCA2 germline — clinically significant nuance, zero code changes |
| Preventive Cardiovascular | PAT003 | Intermediate CVD risk (Reynolds 14.3%) with 3 high-priority gaps missed by standard lipid panel AND population genetic screen: Lp(a), APOE genotype, CAC score |
The same 19-server architecture runs all three. No disease-specific code changes between use cases.
Validated results — PAT001 (HGSOC)
| Metric | Value | Source server |
|---|---|---|
| HRD score | 72 | mcp-genomic-results |
| TMB | 4.2 mut/Mb | mcp-genomic-results |
| Top neoantigen IC50 (RMPEAAPPV) | 7.8 nM | mcp-neoantigen |
| Spatial spot count | 300 | mcp-spatialtools |
| Moran's I (global) | -0.0033 | mcp-spatialtools |
| Deconvolution: tumor | 56 cells | mcp-cibersortx |
| Deconvolution: endothelial | 44 cells | mcp-cibersortx |
| Deconvolution: macrophages | 43 cells | mcp-cibersortx |
| Deconvolution: fibroblasts | 41 cells | mcp-cibersortx |
| Deconvolution: CD8+ T cells | 30 cells | mcp-cibersortx |
Try It
# Clone and explore
git clone https://github.com/lynnlangit/precision-medicine-mcp.git
cd precision-medicine-mcp
# Run tests for any server (DRY_RUN mode, no external deps needed)
cd servers/mcp-multiomics && uv run pytest -v
# Or use Claude Code to explore interactively
claude
All servers default to DRY_RUN mode (mock responses, no API keys needed) for quick validation. Set *_DRY_RUN=false to use synthetic patient data for end-to-end testing.
Learn More
| Audience | Start Here |
|---|---|
| Getting Started | Installation Guide |
| Funders | Executive Summary |
| Hospitals | Hospital Guide |
| Developers | Architecture |
| Researchers | Researcher Guide |
| Educators | Educator Guide |
| All docs | Documentation Index |
Video: 5-minute demo | Paper: Why MCP for Healthcare | External connectors: Setup guide
Known limitations
- DRY_RUN mode returns synthetic data — not for clinical decisions. Set
*_DRY_RUN=falsewith real data for validated results. - GEARS model trained on synthetic GSE184880 subset — retrain on real TCGA data before clinical use.
- Quantum server falls back to CPU on non-CUDA hardware (Apple Silicon, cloud VMs without GPU). Results are identical; training is slower.
Apache 2.0 | Python 3.11+ | FastMCP >= 2.13 | uv for package management
README mirrored from the source repository yesterday. The original is authoritative.